GNOM vs. TMQ

Last updated Apr 2, 2026

Compare and contrast key facts about Global X Genomics & Biotechnology ETF (GNOM) and Trilogy Metals Inc. (TMQ).

GNOM is a passively managed fund by Global X that tracks the performance of the Solactive Genomics Index. It was launched on Apr 5, 2019.

Performance

GNOM vs. TMQ - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Global X Genomics & Biotechnology ETF (GNOM) and Trilogy Metals Inc. (TMQ). The values are adjusted to include any dividend payments, if applicable.

GNOM vs. TMQ - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019
GNOM Global X Genomics & Biotechnology ETF	-2.79%	18.65%	-15.99%	-8.63%	-36.27%	-15.93%	51.52%	1.56%
TMQ Trilogy Metals Inc.	-12.53%	271.55%	169.77%	-21.82%	-66.67%	-17.50%	-23.08%	3.17%

Returns By Period

In the year-to-date period, GNOM achieves a -2.79% return, which is significantly higher than TMQ's -12.53% return.

GNOM

• 1D: 1.02%
• 1M: -6.22%
• YTD: -2.79%
• 6M: 12.23%
• 1Y: 44.15%
• 3Y*: -3.13%
• 5Y*: -13.13%
• 10Y*: —

TMQ

• 1D: 5.01%
• 1M: -16.78%
• YTD: -12.53%
• 6M: 65.35%
• 1Y: 137.11%
• 3Y*: 91.96%
• 5Y*: 11.58%
• 10Y*: 26.13%

*Multi-year figures are annualized to reflect compound growth (CAGR)

Return for Risk

GNOM vs. TMQ — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

GNOM

GNOM Risk / Return Rank: 73
GNOM Sharpe Ratio Rank: 75
GNOM Sortino Ratio Rank: 77
GNOM Omega Ratio Rank: 68
GNOM Calmar Ratio Rank: 78
GNOM Martin Ratio Rank: 69

TMQ

TMQ Risk / Return Rank: 79
TMQ Sharpe Ratio Rank: 61
TMQ Sortino Ratio Rank: 96
TMQ Omega Ratio Rank: 93
TMQ Calmar Ratio Rank: 77
TMQ Martin Ratio Rank: 69

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

GNOM vs. TMQ - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Global X Genomics & Biotechnology ETF (GNOM) and Trilogy Metals Inc. (TMQ). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	GNOM	TMQ	Difference
Sharpe ratio Return per unit of total volatility	1.43	0.58	+0.84
Sortino ratio Return per unit of downside risk	2.04	3.72	-1.68
Omega ratio Gain probability vs. loss probability	1.26	1.45	-0.20
Calmar ratio Return relative to maximum drawdown	2.25	2.06	+0.19
Martin ratio Return relative to average drawdown	7.43	3.53	+3.90
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

GNOM vs. TMQ - Sharpe Ratio Comparison

The current GNOM Sharpe Ratio is 1.43, which is higher than the TMQ Sharpe Ratio of 0.58. The chart below compares the historical Sharpe Ratios of GNOM and TMQ, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Sharpe Ratios by Period

	GNOM	TMQ	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	1.43	0.58	+0.84
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	-0.39	0.09	-0.48
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	—	0.26	—
Sharpe Ratio (All Time) Calculated using the full available price history	-0.13	-0.02	-0.11

Correlation

The correlation between GNOM and TMQ is 0.23, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Dividends

GNOM vs. TMQ - Dividend Comparison

GNOM's dividend yield for the trailing twelve months is around 1.41%, while TMQ has not paid dividends to shareholders.

	TTM	2025	2024	2023	2022	2021	2020
GNOM Global X Genomics & Biotechnology ETF	1.41%	1.37%	0.00%	0.00%	0.00%	0.03%	0.14%
TMQ Trilogy Metals Inc.	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Drawdowns

GNOM vs. TMQ - Drawdown Comparison

The maximum GNOM drawdown since its inception was -75.00%, smaller than the maximum TMQ drawdown of -96.55%. Use the drawdown chart below to compare losses from any high point for GNOM and TMQ.

Drawdown Indicators

	GNOM	TMQ	Difference
Max Drawdown Largest peak-to-trough decline	-75.00%	-96.55%	+21.55%
Max Drawdown (1Y) Largest decline over 1 year	-18.17%	-69.62%	+51.45%
Max Drawdown (5Y) Largest decline over 5 years	-72.29%	-87.61%	+15.32%
Max Drawdown (10Y) Largest decline over 10 years	—	-88.01%	—
Current Drawdown Current decline from peak	-59.83%	-64.43%	+4.60%
Average Drawdown Average peak-to-trough decline	-40.12%	-72.11%	+31.99%
Ulcer Index Depth and duration of drawdowns from previous peaks	5.51%	40.57%	-35.06%

Volatility

GNOM vs. TMQ - Volatility Comparison

The current volatility for Global X Genomics & Biotechnology ETF (GNOM) is 10.76%, while Trilogy Metals Inc. (TMQ) has a volatility of 19.20%. This indicates that GNOM experiences smaller price fluctuations and is considered to be less risky than TMQ based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	GNOM	TMQ	Difference
Volatility (1M) Calculated over the trailing 1-month period	10.76%	19.20%	-8.44%
Volatility (6M) Calculated over the trailing 6-month period	19.71%	142.85%	-123.14%
Volatility (1Y) Calculated over the trailing 1-year period	31.21%	237.38%	-206.17%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	33.65%	128.10%	-94.45%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	34.30%	102.28%	-67.98%